Skip to main content

BUSQUEDA DE BIOMARCADORES PRONOSTICOS PARA PERSONALIZAR EL TRATAMIENTO DE LA TUBERCULOSIS.

PI20/01424

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION INSTITUTO INV GERMANS TRIAS I PUJOL
Execution centre INSTITUTO DE INVESTIGACION GERMANS TRIAS I PUJOL (IGTP)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country, a case series analysis

  • Roure, Silvia|||0000-0002-7982-0890
  • Vallès, Xavier|||0000-0002-4445-1490
  • Sopena, Nieves|||0000-0001-6382-9500
  • Benítez Díaz, Rosa María|||0000-0001-6972-6094
  • Reynaga, Esteban|||0000-0002-4069-6087
  • Bracke Manzanares, Carmen|||0000-0002-0306-8321
  • Loste, Cora
  • Mateu, Lourdes|||0000-0001-7223-7611
  • Antuori Torres, Adrián|||0000-0002-2782-3125
  • Baena, Tania
  • Portela, Germán
  • Llussà, Judith|||0000-0002-6886-6084
  • Flamarich, Clara|||0000-0002-2784-6108
  • Soldevila Langa, Laura|||0000-0002-3324-0225
  • Tenesa Bordas, Montserrat|||0000-0002-9729-090X
  • Pérez, Ricard
  • Plasencia, Elsa
  • Bechini Bernad, Jordi|||0000-0001-7735-0621
  • Pedro Botet, Maria Luisa|||0000-0001-7252-3191
  • Clotet Sala, Bonaventura|||0000-0003-3232-4598
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
Disseminated tuberculosis is frequently associated with delayed diagnosis and a poorer prognosis. To describe case series of disseminated TB and diagnosis delay in a low TB burden country during the COVID-19 period. We consecutively included all patients with of disseminated TB reported from 2019 to 2021 in the reference hospital of the Northern Crown of the Metropolitan Area of Barcelona. We collected socio-demographic information, clinical, laboratory and radiological findings. We included all 30 patients reported during the study period-5, 9, and 16 in 2019, 2020, and 2021 respectively-20 (66.7%) of whom were male and whose mean age was 41 years. Twenty-five (83.3%) were of non-EU origin. The most frequent system involvement was central nervous system (N = 8; 26.7%) followed by visceral (N = 7; 23.3%), gastro-intestinal (N = 6, 20.0%), musculoskeletal (N = 5; 16.7%), and pulmonary (N = 4; 13.3%). Hypoalbuminemia and anemia were highly prevalent (72 and 77%). The median of diagnostic delay was 6.5 months (IQR 1.8-30), which was higher among women (36.0 vs. 3.5 months; p = 0.002). Central nervous system involvement and pulmonary involvement were associated with diagnostic delay among women. We recorded 24 cured patients, two deaths, three patients with post-treatment sequelae, and one lost-to-follow up. We observed a clustering effect of patients in low-income neighborhoods (p < 0.001). There was a substantial delay in the diagnosis of disseminated TB in our study region, which might impacted the prognosis with women affected more negatively. Our results suggest that an increase in the occurrence of disseminated TB set in motion by diagnosis delay may have been a secondary effect of the COVID-19 pandemic.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A longitudinal prospective study of active tuberculosis in a Western Europe setting, insights and findings

  • Romero-Tamarit, Arantxa
  • Vallès, Xavier|||0000-0002-4445-1490
  • Munar-García, María
  • Espinosa-Pereiro, Juan|||0000-0002-7238-8337
  • Saborit, Núria
  • Tórtola Fernández, María Teresa|||0000-0002-9188-298X
  • Stojanovic, Zoran|||0000-0001-5082-0750
  • Roure, Silvia|||0000-0002-7982-0890
  • Antuori Torres, Adrián|||0000-0002-2782-3125
  • Cardona, Pere-Joan|||0000-0001-5623-7873
  • Soriano-Arandes, Antoni|||0000-0001-9613-7228
  • Martín Nalda, Andrea|||0000-0002-1715-153X
  • Espiau, María|||0000-0001-9697-7649
  • De Souza Galvão, Maria Luiza|||0000-0001-9703-989X
  • Jiménez, Ma. Ángeles
  • Noguera-Julian, Antoni|||0000-0001-7485-0583
  • Molina Romero, Israel|||0000-0001-6642-7515
  • Casas, Xavier|||0000-0002-3892-9697
  • Domínguez-Álvarez, Marisol
  • Jové, Neus
  • Gogichadze, Nino|||0000-0001-7014-1608
  • Fonseca, Kaori L.|||0000-0002-7048-9740
  • Arias, Lilibeth|||0000-0002-2469-8832
  • Millet, Joan Pau|||0000-0003-0200-2459
  • Sánchez Montalvá, Adrián|||0000-0002-2194-5447
  • Vilaplana Massaguer, Cristina|||0000-0002-2808-7270
This study investigates the potential of inflammatory parameters (IP), symptoms, and patient-related outcome measurements as biomarkers of severity and their ability to predict tuberculosis (TB) evolution. People with TB were included prospectively in the Stage-TB study conducted at five clinical sites in Barcelona (Spain) between April 2018 and December 2021. Data on demographics, epidemiology, clinical features, microbiology, and Sanit George Respiratory Questionnaire (SGRQ) and Kessler-10 as Health-Related Quality of Life (HRQoL) were collected at three time points during treatment. C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), neutrophil/lymphocyte, and monocyte/lymphocyte ratios (NLR and MLR), complement factors C3, C4, and cH50, clinical and microbiological data, and HRQoL questionnaires were assessed at baseline, 2 months, and 6 months. Their ability to predict sputum culture conversion (SCC) and symptom presence after 2 months of treatment was also analysed. The study included 81 adults and 13 children with TB. The CRP, ESR, NLR, and MLR values, as well as the presence of symptoms, decreased significantly over time in both groups. Higher IP levels at baseline were associated with greater bacillary load and persistent symptoms. Clinical severity at baseline predicted a delayed SCC. Kessler-10 improved during follow-up, but self-reported lung impairment (SGRQ) persisted in all individuals after 6 months. IP levels may indicate disease severity, and sustained high levels are linked to lower treatment efficacy. Baseline clinical severity is the best predictor of SCC. Implementing health strategies to evaluate lung function and mental health throughout the disease process may be crucial for individuals with TB. The online version contains supplementary material available at 10.1007/s15010-024-02184-2.